PROCEPT BioRobotics Corporation (PRCT)
USD 82.14
(-7.25%)
USD 82.14
(-7.25%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -108 Million | -80.38 Million | -57.33 Million | -48.34 Million | -43.81 Million |
| Net Income | -105.89 Million | -87.15 Million | -59.85 Million | -53.01 Million | -41.97 Million |
| Depreciation & Amortization | 3.8 Million | 2.84 Million | 3.32 Million | 2.86 Million | 1.49 Million |
| Deferred income taxes | 26.31 Million | - | 451 Thousand | 223 Thousand | - |
| Stock-based compensation | 19.13 Million | 10.33 Million | 3.79 Million | 2.17 Million | 1.99 Million |
| Change in working capital | -26.16 Million | -11.48 Million | -4.7 Million | -483 Thousand | -3.53 Million |
| Other non-cash items | -25.2 Million | 5.08 Million | -345 Thousand | -97 Thousand | -1.79 Million |
| Investing Cash Flow | -25.2 Million | -2.65 Million | -592 Thousand | -233 Thousand | 43.15 Million |
| Investments in PPE | -25.2 Million | -2.65 Million | -592 Thousand | -233 Thousand | -7.61 Million |
| Acquisitions | - | - | - | - | - |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | 50.76 Million |
| Other Investing Activities | - | - | - | - | 50.76 Million |
| Financing Cash Flow | 167.79 Million | 3.61 Million | 262.11 Million | 106.77 Million | 26.52 Million |
| Debt repayment | - | -2.8 Million | - | -24.68 Million | -24.53 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | 3.61 Million | 2.4 Million | - | - | - |
| Common Stock Issuance | 167.79 Million | 6.41 Million | 262.11 Million | 82.08 Million | 1.99 Million |
| Other Financing Activities | 167.79 Million | -4 Million | 262.11 Million | 49.37 Million | 49.06 Million |
| Accounts receivables | -33.1 Million | -10.8 Million | -2.91 Million | -511 Thousand | 522 Thousand |
| Accounts payables | 5.78 Million | 3.95 Million | 812 Thousand | -205 Thousand | -260 Thousand |
| Inventory | -9.75 Million | -15.25 Million | -6.12 Million | -3.1 Million | -5.07 Million |
| Other working capital | 10.9 Million | 10.61 Million | 3.51 Million | 3.33 Million | 1.28 Million |
| Cash at beginning of period | 222.63 Million | 305.09 Million | 100.9 Million | 42.71 Million | 16.85 Million |
| Cash at end of period | 257.22 Million | 225.67 Million | 305.09 Million | 100.9 Million | 42.71 Million |
| Capital Expenditure | -25.2 Million | -2.65 Million | -592 Thousand | -233 Thousand | -7.61 Million |
| Effect of forex changes on cash | -1.00 | - | - | - | - |
| Net cash flow / Change in cash | 34.58 Million | -79.42 Million | 204.19 Million | 58.19 Million | 25.86 Million |
| Free Cash Flow | -133.2 Million | -83.03 Million | -57.92 Million | -48.57 Million | -51.42 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -20.97 Million | -25.62 Million | -25.95 Million | -105.89 Million | -27.5 Million | -24.62 Million |
| Depreciation & Amortization | 1.32 Million | 1.26 Million | 1.18 Million | 3.8 Million | 1.31 Million | 1.05 Million |
| Deferred income taxes | - | - | - | 26.31 Million | -12.3 Million | -4.36 Million |
| Stock-based compensation | 8.51 Million | 7.98 Million | 6.25 Million | 19.13 Million | 4.98 Million | 5.32 Million |
| Change in working capital | -8.46 Million | -203 Thousand | -13.7 Million | -26.16 Million | -3.5 Million | -1.11 Million |
| Other non-cash items | 794 Thousand | 16.64 Million | -96 Thousand | -25.2 Million | 12.22 Million | 4.77 Million |
| Investing Cash Flow | -246 Thousand | -1.04 Million | -1.94 Million | -25.2 Million | -8.71 Million | -5.78 Million |
| Investments in PPE | -246 Thousand | -1.04 Million | -1.94 Million | -25.2 Million | -8.71 Million | -5.78 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 1.71 Million | 5.29 Million | 2.58 Million | 167.79 Million | 2.86 Million | 162.11 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 2.12 Million | - | - | 3.61 Million | 3.61 Million | - |
| Common Stock Issuance | -7.88 Million | 5.29 Million | 2.58 Million | 167.79 Million | 2.86 Million | 162.11 Million |
| Other Financing Activities | 1.71 Million | 5.29 Million | 2.58 Million | 167.79 Million | 2.86 Million | 162.11 Million |
| Accounts receivables | -10.58 Million | -2.83 Million | -7.7 Million | -33.1 Million | -13.75 Million | -1.44 Million |
| Accounts payables | 5.19 Million | 344 Thousand | -2.31 Million | 5.78 Million | 5.87 Million | -2.32 Million |
| Inventory | -7.15 Million | -2.79 Million | -1.48 Million | -9.75 Million | 3.18 Million | 485 Thousand |
| Other working capital | 4.09 Million | 5.08 Million | 2.8 Million | 10.9 Million | 1.18 Million | 2.16 Million |
| Cash at beginning of period | 217.13 Million | 225.57 Million | 260.26 Million | 222.63 Million | 287.86 Million | 153.5 Million |
| Cash at end of period | 199.8 Million | 214.09 Million | 228.61 Million | 257.22 Million | 257.22 Million | 290.9 Million |
| Capital Expenditure | -246 Thousand | -1.04 Million | -1.94 Million | -25.2 Million | -8.71 Million | -5.78 Million |
| Effect of forex changes on cash | - | - | - | -1.00 | -1.00 | - |
| Net cash flow / Change in cash | -17.33 Million | -11.48 Million | -31.64 Million | 34.58 Million | -30.64 Million | 137.39 Million |
| Free Cash Flow | -19.04 Million | -16.77 Million | -34.23 Million | -133.2 Million | -33.5 Million | -24.72 Million |
FCPB
8403
JAWA
OYAKC
CBNK
3093